On 5/2/24, Actinium Pharmaceuticals Inc (NYSEAMERICAN: ATNM) stock enjoyed a major increase of 12.5%, closing at $8.75. Moreover, unusually high trading volume at 158% of normal accompanied the advance. The stock has risen 23.9% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
ATNM is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
Actinium Pharmaceuticals has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Actinium Pharmaceuticals has a very low Appreciation Score of 1 but a good Power Rating of 78, and the Negative Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment